Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 08 04:00PM ET
108.52
Dollar change
-0.07
Percentage change
-0.06
%
IndexDJIA, S&P 500 P/E20.11 EPS (ttm)5.40 Insider Own0.10% Shs Outstand2.53B Perf Week-5.42%
Market Cap275.08B Forward P/E11.17 EPS next Y9.71 Insider Trans0.00% Shs Float2.53B Perf Month-5.97%
Income13.74B PEG0.83 EPS next Q1.64 Inst Own78.85% Short Float0.98% Perf Quarter-14.75%
Sales62.19B P/S4.42 EPS this Y424.22% Inst Trans0.86% Short Ratio2.65 Perf Half Y-14.36%
Book/sh17.19 P/B6.31 EPS next Y22.68% ROA12.65% Short Interest24.81M Perf Year4.47%
Cash/sh4.50 P/C24.14 EPS next 5Y24.25% ROE33.39% 52W Range99.14 - 134.63 Perf YTD-0.46%
Dividend Est.3.14 (2.89%) P/FCF20.92 EPS past 5Y-42.70% ROI17.54% 52W High-19.39% Beta0.41
Dividend TTM3.08 (2.84%) Quick Ratio1.22 Sales past 5Y7.72% Gross Margin72.33% 52W Low9.46% ATR (14)1.96
Dividend Ex-DateSep 16, 2024 Current Ratio1.47 EPS Y/Y TTM340.50% Oper. Margin26.04% RSI (14)28.50 Volatility1.74% 1.59%
Employees72000 Debt/Eq0.87 Sales Y/Y TTM8.43% Profit Margin22.09% Recom1.48 Target Price139.40
Option/ShortYes / Yes LT Debt/Eq0.80 EPS Q/Q191.12% Payout2065.60% Rel Volume0.94 Prev Close108.59
Sales Surprise1.53% EPS Surprise5.17% Sales Q/Q7.25% EarningsOct 31 BMO Avg Volume9.36M Price108.52
SMA20-5.00% SMA50-5.46% SMA200-11.59% Trades Volume8,815,721 Change-0.06%
Date Action Analyst Rating Change Price Target Change
Mar-11-24Downgrade Societe Generale Hold → Sell $104
Jan-04-24Upgrade TD Cowen Market Perform → Outperform $125 → $135
Nov-09-23Initiated Deutsche Bank Buy $115
Oct-27-23Upgrade BMO Capital Markets Market Perform → Outperform $132
Oct-20-23Upgrade UBS Neutral → Buy $117 → $122
Jul-14-23Initiated HSBC Securities Hold $123
Apr-13-23Upgrade Citigroup Neutral → Buy $105 → $130
Mar-28-23Downgrade Societe Generale Buy → Hold
Mar-13-23Downgrade Wells Fargo Overweight → Equal Weight $120 → $115
Mar-06-23Initiated Jefferies Buy $125
Today 03:44PM
06:45AM
Oct-07-24 06:33AM
Oct-06-24 03:36PM
Oct-04-24 09:40AM
08:30AM Loading…
Oct-03-24 08:30AM
08:30AM
Oct-01-24 06:45AM
06:30AM
Sep-30-24 12:30PM
04:50AM
Sep-29-24 06:28AM
Sep-27-24 12:09PM
06:38AM
Sep-26-24 12:23PM
06:45AM Loading…
06:45AM
04:27AM
Sep-25-24 03:54PM
08:32AM
06:45AM
06:30AM
12:11AM
Sep-24-24 08:06AM
Sep-20-24 10:48AM
09:00AM
07:30AM
Sep-19-24 09:00AM
Sep-18-24 02:45PM
06:45AM
04:52AM
07:58AM Loading…
Sep-17-24 07:58AM
07:51AM
06:00AM
Sep-16-24 07:00AM
Sep-15-24 10:30AM
08:45AM
Sep-14-24 12:40PM
10:47AM
10:35AM
10:30AM
08:10AM
03:15AM
Sep-12-24 03:10PM
07:00AM
12:25AM
Sep-11-24 06:45AM
06:30AM
Sep-09-24 01:55PM
09:59AM
08:02AM
Sep-07-24 11:30AM
Sep-06-24 06:14PM
12:10PM
Sep-05-24 07:00AM
04:32AM
Sep-04-24 03:00PM
06:45AM
06:40AM
04:12AM
Sep-03-24 11:32PM
01:22PM
09:40AM
08:10AM
06:45AM
Aug-29-24 10:35AM
09:33AM
07:30AM
06:45AM
06:30AM
Aug-28-24 04:52AM
Aug-27-24 08:52AM
07:35AM
06:45AM
05:32AM
Aug-26-24 03:22PM
12:00PM
06:45AM
Aug-23-24 02:10PM
09:00AM
Aug-22-24 07:00AM
Aug-21-24 09:29AM
Aug-19-24 08:04AM
Aug-17-24 03:21PM
Aug-16-24 08:54PM
06:09PM
Aug-15-24 05:30PM
12:34PM
10:49AM
07:49AM
Aug-14-24 06:15AM
Aug-09-24 03:33PM
03:18PM
08:09AM
06:45AM
06:32AM
05:59AM
Aug-08-24 12:23PM
09:00AM
06:45AM
Aug-07-24 07:57AM
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Guindo ChirfiChief Marketing OfficerAug 05 '24Option Exercise115.2036,9014,250,99557,782Aug 06 12:20 PM
Smart DaltonSVP Fin. - Global ControllerMay 03 '24Option Exercise128.262,046262,4204,708May 06 04:10 PM
Smart DaltonSVP Fin. - Global ControllerMay 04 '24Option Exercise127.5161278,0364,730May 06 04:10 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthMay 04 '24Option Exercise127.5127,1263,458,836163,720May 06 04:08 PM
Klobuchar Michael AEVP - Chief Strategy OfficerMay 04 '24Option Exercise127.51887113,10124,058May 06 04:06 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketMay 04 '24Option Exercise127.51912116,28924,271May 06 04:01 PM
Romanelli JosephPresident, Human Health Int?lMay 02 '24Option Exercise128.802,262291,34621,831May 02 04:29 PM
Smart DaltonSVP Fin. - Global ControllerMay 02 '24Option Exercise128.8038149,0733,048May 02 04:23 PM
Merck & Co., Inc.10% OwnerMar 11 '24Buy23.0021,397,205492,135,7151,000Mar 11 03:27 PM
Litchfield CarolineEVP & CFOFeb 14 '24Option Exercise58.0838,2912,223,94189,199Feb 15 04:03 PM
Litchfield CarolineEVP & CFOFeb 14 '24Sale125.5038,2914,805,52050,908Feb 15 04:03 PM
Davis Robert MChairman, CEO & PresidentFeb 13 '24Option Exercise74.18150,00011,127,160498,327Feb 15 04:01 PM
Davis Robert MChairman, CEO & PresidentFeb 14 '24Option Exercise73.7385,0216,268,598433,348Feb 15 04:01 PM
Davis Robert MChairman, CEO & PresidentFeb 13 '24Sale125.85150,00018,877,424348,327Feb 15 04:01 PM
Davis Robert MChairman, CEO & PresidentFeb 14 '24Sale125.4085,02110,661,574348,327Feb 15 04:01 PM
Romanelli JosephPresident, Human Health Int?lFeb 13 '24Sale124.891,000124,88819,569Feb 14 04:03 PM
Li Dean YExecutive VP & President, MRLFeb 09 '24Option Exercise62.0714,702912,55360,944Feb 12 04:03 PM
Li Dean YExecutive VP & President, MRLFeb 09 '24Sale125.5014,7021,845,08346,242Feb 12 04:03 PM
Williams David MichaelEVP,Chief Info&Digital OfficerFeb 07 '24Sale127.571,451185,10819,812Feb 08 04:04 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketFeb 02 '24Option Exercise78.8020,9371,649,90642,286Feb 05 04:01 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketFeb 02 '24Sale127.1718,9592,411,11123,327Feb 05 04:01 PM
MIZELL STEVENEVP, Chief HR OfficerFeb 02 '24Option Exercise73.6532,9942,430,15974,313Feb 02 04:07 PM
MIZELL STEVENEVP, Chief HR OfficerFeb 02 '24Sale126.6550,6946,420,34923,619Feb 02 04:07 PM
Zachary JenniferEVP, General CounselFeb 02 '24Option Exercise87.1019,4171,691,22178,557Feb 02 04:05 PM
Zachary JenniferEVP, General CounselFeb 02 '24Sale126.9749,4996,284,77929,058Feb 02 04:05 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketNov 09 '23Sale102.382,081213,06118,191Nov 13 07:36 AM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthNov 08 '23Sale105.0343,8234,602,668111,764Nov 09 09:04 AM
Oosthuizen Johannes JacobusPresident, U.S. MarketOct 30 '23Option Exercise102.8291594,08020,723Oct 31 11:08 AM